The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA.
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Michiel Van Der Heijden
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Seagen (Inst)
Research Funding - 4SC (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst)
 
Ying Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
James Catto
Consulting or Advisory Role - AstraZeneca/MedImmune; Ferring; Janssen; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca/MedImmune; Bristol Myers Squibb Foundation; ipsen; Medac; Pfizer; Roche
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Janssen medical Affairs
 
Joshua Meeks
Honoraria - Astellas Pharma; AstraZeneca; bristol meyers; CG Oncology; ferring; ImmunityBio; Imvax; Janssen; Merck; Pfizer; Photocure; Prokarium; Protara Therapeutics; Urogen pharma
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Hikmat Al-Ahmadie
Consulting or Advisory Role - AstraZeneca/MedImmune; PAIGE.AI; Pfizer
 
Hiroyuki Nishiyama
Honoraria - Astellas Pharma; AstraZeneca/Merck; Bristol Myers Squibb Foundation; Merck; MSD; Nippon Kayaku; Ono Pharmaceutical
Consulting or Advisory Role - Janssen; Merck Sharp & Dohme; Ono Pharmaceutical
Research Funding - Astellas Pharma; Chugai Pharma; Johnson & Johnson
 
Toan Vu
No Relationships to Disclose
 
Lorenzo Antonuzzo
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Novartis
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck Serono
 
Tae-Hwan Kim
No Relationships to Disclose
 
Vagif Atduev
No Relationships to Disclose
 
Bernhard Eigl
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EMD Serono/Merck; Gilead Sciences; Janssen; Merck; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - EMD Serono; Gilead Sciences
Travel, Accommodations, Expenses - EMD Serono
 
Yousef Zakharia
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; EMD Serono; Exelixis; Genzyme; Gilead Sciences; Janssen; Novartis; Pfizer
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Kazuo Nishimura
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Ono Pharmaceutical
 
Svetlana Ho
Employment - AstraZeneca
 
Wenjing Xin
Employment - AstraZeneca
 
Yashaswi Shrestha
Employment - AstraZeneca
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792